Compare · HDSN vs SNN
HDSN vs SNN
Side-by-side comparison of Hudson Technologies Inc. (HDSN) and Smith & Nephew SNATS Inc. (SNN): market cap, price performance, sector, and recent activity on the wire.
Summary
- HDSN operates in Consumer Discretionary, while SNN operates in Health Care - the two are in different parts of the market.
- SNN is the larger of the two at $13.00B, about 50.1x HDSN ($259.6M).
- Over the past year, HDSN is down 24.7% and SNN is up 1.5% - SNN leads by 26.2 points.
- HDSN has been more active in the news (10 items in the past 4 weeks vs 7 for SNN).
- SNN has more recent analyst coverage (23 ratings vs 11 for HDSN).
- Company
- Hudson Technologies Inc.
- Smith & Nephew SNATS Inc.
- Price
- $6.18-2.06%
- $30.60-2.55%
- Market cap
- $259.6M
- $13.00B
- 1M return
- +11.05%
- +0.36%
- 1Y return
- -24.73%
- +1.48%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 10
- 7
- Recent ratings
- 11
- 23
Hudson Technologies Inc.
Hudson Technologies, Inc. a refrigerant services company, provides solutions to recurring problems within the refrigeration industry primarily in the United States. The company's products and services include refrigerant and industrial gas sales; refrigerant management services consisting primarily of reclamation of refrigerants, re-usable cylinder refurbishment, and hydrostatic testing services; and RefrigerantSide services comprising system decontamination to remove moisture, oils, and other contaminants. It also offers SmartEnergy OPS service, a web-based real time continuous monitoring service; and Chiller Chemistry and Chill Smart services. In addition, the company participates in the generation of carbon offset projects. It serves commercial, industrial, and governmental customers, as well as refrigerant wholesalers, distributors, contractors, and refrigeration equipment manufacturers. Hudson Technologies, Inc. was founded in 1991 and is headquartered in Pearl River, New York.
Smith & Nephew SNATS Inc.
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
Latest HDSN
- Amendment: SEC Form SCHEDULE 13G/A filed by Hudson Technologies Inc.
- Large owner Hartree Partners, Lp bought $31,352 worth of shares (5,234 units at $5.99), increasing direct ownership by 0.11% to 4,976,536 units (SEC Form 4)
- Large owner Hartree Partners, Lp bought $4,477,207 worth of shares (764,202 units at $5.86), increasing direct ownership by 18% to 4,971,302 units (SEC Form 4)
- New insider Hartree Partners, Lp claimed ownership of 4,207,100 shares (SEC Form 3)
- Director Sheriff Alan was granted 3,219 shares, increasing direct ownership by 35% to 12,484 units (SEC Form 4)
- Director Prouty Eric A was granted 4,440 shares, increasing direct ownership by 3% to 158,292 units (SEC Form 4)
- SEC Form 4 filed by Director Parrillo Richard
- Director Mansy Loan Nguyen was granted 8,881 shares, increasing direct ownership by 35% to 34,476 units (SEC Form 4)
- SEC Form 4 filed by Director Bulgarino Nicole E
- Director Feeler Jeffrey R was granted 3,219 shares, increasing direct ownership by 35% to 12,384 units (SEC Form 4)
Latest SNN
- Smith+Nephew introduces groundbreaking LYNX™ COBLATION™ Laryngeal Wand for ENT surgeons
- New German expert consensus provides first risk-based recommendations for sNPWT use in closed surgical incisions
- New German expert consensus highlights role for NPWT in mitigating the economic impact of postoperative wound complications
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- Fresh Off Its Nasdaq Debut, a Regenerative-Medicine Upstart Is Stacking Its Board With Big-Pharma Firepower
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.